[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![awakn_ls Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1265596823818907648.png) Solvonis Therapeutics plc [@awakn_ls](/creator/twitter/awakn_ls) on x 8581 followers
Created: 2025-07-18 09:31:30 UTC

Solvonis is advancing SVN‑002 under the FDA’s 505(b)(2) pathway, referencing J&J’s $1B+ blockbuster Spravato®.

SVN‑002 targets moderate-to-severe #AUD with a differentiated formulation for addiction clinics.

#SVN002 #505b2 #Spravato #AddictionTreatment #Solvonis $SVNS

![](https://pbs.twimg.com/media/GwIUsrIXkAA826-.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946140765886800278/c:line.svg)

**Related Topics**
[australian dollar](/topic/australian-dollar)
[$svns](/topic/$svns)
[$1b](/topic/$1b)

[Post Link](https://x.com/awakn_ls/status/1946140765886800278)